Shao D, Narayanan S, Shah S, Ramesh V
Use of intermediate clinical endpoints (ICE) as a primary efficacy endpoint in malignant melanoma.
18July
Use of intermediate clinical endpoints (ICE) as a primary efficacy endpoint in malignant melanoma.